These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10765310)

  • 1. Home care for stem cell transplantation patients.
    MacRae K; Humphreys A; Lind M
    Prof Nurse; 1999 Nov; 15(2):87-90. PubMed ID: 10765310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose therapy for treatment of breast cancer.
    Anderson-Reitz L; Mechling BE; Hertz SL
    Nurse Pract Forum; 1999 Sep; 10(3):154-8. PubMed ID: 10614360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition.
    Svahn BM; Remberger M; Heijbel M; Martell E; Wikström M; Eriksson B; Milovsavljevic R; Mattsson J; Ringdén O
    Transplantation; 2008 Apr; 85(7):1000-7. PubMed ID: 18408581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical pathway for administering high-dose chemotherapy followed by peripheral blood stem cell rescue in the outpatient setting.
    Burns JM; Tierney DK; Long GD; Lambert SC; Carr BE
    Oncol Nurs Forum; 1995 Sep; 22(8):1219-24. PubMed ID: 8532546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.
    Holmberg LA; Oparin DV; Gooley T; Lilleby K; Bensinger W; Reddish MA; MacLean GD; Longenecker BM; Sandmaier BM
    Bone Marrow Transplant; 2000 Jun; 25(12):1233-41. PubMed ID: 10871727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT.
    Neymark N; Rosti G
    Haematologica; 2000 Jul; 85(7):733-44. PubMed ID: 10897126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.
    Pedrazzoli P; Ferrante P; Kulekci A; Schiavo R; De Giorgi U; Carminati O; Marangolo M; Demirer T; Siena S; Rosti G;
    Bone Marrow Transplant; 2003 Sep; 32(5):489-94. PubMed ID: 12942095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancer.
    Wang X; Tang J; Wu J; Feng J; Pang L; Dai A; Zheng X
    Bone Marrow Transplant; 2001 Feb; 27(3):345-6. PubMed ID: 11277186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
    Cheng YC; Rondón G; Yang Y; Smith TL; Gajewski JL; Donato ML; Shpall EJ; Jones R; Hortobagyi GN; Champlin RE; Ueno NT
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):794-804. PubMed ID: 15505610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
    Stemmer SM; Pfeffer MR; Rizel S; Hardan I; Goffman J; Gezin A; Neumann A; Kitsios P; Alezra D; Brenner HJ
    Cancer; 2001 Jun; 91(11):1983-91. PubMed ID: 11391576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer.
    Okumura A; Tokuda Y; Ohta M; Suzuki Y; Saito Y; Kuge S; Kubota M; Makuuchi H; Tajima T; Nakamura Y; Hotta T
    Tokai J Exp Clin Med; 1999 Dec; 24(4-6):141-6. PubMed ID: 10819494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation.
    Pecora AL; Stiff P; LeMaistre CF; Bayer R; Bachier C; Goldberg SL; Parthasarathy M; Jennis AA; Smith AK; Douville J; Chen B; Armstrong RD; Mandalam RK; Preti R
    Bone Marrow Transplant; 2001 Aug; 28(3):295-303. PubMed ID: 11535999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantation.
    Solano C; Badia B; Lluch A; Marugan I; Benet I; Arbona C; Prosper F; García-Conde J
    Bone Marrow Transplant; 2001 Feb; 27(3):287-93. PubMed ID: 11277176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
    Ayash LJ; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M
    Hum Gene Ther; 2001 Nov; 12(16):2023-5. PubMed ID: 11727734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
    Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN
    Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of extracorporeal peripheral blood stem cell apheresis on platelet antigens.
    Gutensohn K; Hummel K; Goepfert C; Riggert J; Cassens U; Kuehnl P
    Beitr Infusionsther Transfusionsmed; 1997; 34():153-6. PubMed ID: 9356667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.